Efficacy of Combination Blinatumomab and Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) and Chronic Myeloid Leukemia in Lymphoid Blast Phase (CMLBP) in a Real World Setting

被引：0

作者：

Tobon, Katherine ^{[1
]}

Consalvo, Kylie ^{[2
]}

Kareem, Syeda Saba ^{[1
]}

Lancet, Jeffrey E. ^{[1
]}

Komrokji, Rami S. ^{[1
]}

Pinilla-Ibarz, Javier ^{[3
]}

Sallman, David ^{[1
]}

Eatrides, Jennifer ^{[4
]}

Walker, Alison R. ^{[1
]}

Chavez, Julio C. ^{[1
]}

Isenalumhe, Leidy Lismeris ^{[1
]}

Shah, Bijal ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Community & Satellite Oncol, Tampa, FL USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-201486

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2821 / 2821

页数：1

共 50 条

[1] Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis
Kolenova, Alexandra
Maloney, Kelly W.
Hunger, Stephen P.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : E193 - E195
[2] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Narayanan, V.
Pollyea, D. A.
Gutman, J. A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
[3] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Short, Nicholas James
Jabbour, Elias
Jain, Nitin
Macaron, Walid
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Haddad, Fadi
Zoghbi, Marianne
Nasnas, Cedric Christophe
Nasr, Lewis Fady
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[4] A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Bravo, Guillermo Montalban
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan M.
Valero, Yesid Alvarado
Chien, Kelly Sharon
Daver, Naval Guastad
Macaron, Walid
Sasaki, Koji
Thankachan, Jennifer
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Loiselle, Christopher
Kwari, Monica
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] Ponatinib and Blinatumomab for Patients with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Phase: A Subgroup Analysis from a Phase II Study
Macaron, Walid
Kantarjian, Hagop
Short, Nicholas
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval
Chien, Kelly S.
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas C.
Haddad, Fadi
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2022, 140 : 8973 - 8975
[6] Phase II study of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia
Sasaki, Koji
Kantarjian, Hagop
Konopleva, Marina
Jain, Nitin
Huang Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Short, Nicholas
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
ANNALS OF ONCOLOGY, 2022, 33 : S466 - S466
[7] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Couturier, Marie-Anne
Thomas, Xavier
Raffoux, Emmanuel
Huguet, Francoise
Berthon, Celine
Simand, Celestine
Gallego-Hernanz, Maria-Pilar
Hicheri, Yosr
Berger, Mathilde Hunault
Saillard, Colombe
Leguay, Thibaut
Loiseau, Clemence
Bene, Marie-Christine
Chevallier, Patrice
LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
[8] Subgroup analysis from a phase II trial of ponatinib and blinatumomab in relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase
Zoghbi, Marianne
Jabbour, Elias
Haddad, Fadi
Short, Nicholas James
Nasnas, Cedric Christophe
Macaron, Walid
Nasr, Lewis Fady
Jain, Nitin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Chien, Kelly Sharon
Valero, Yesid Alvarado
Issa, Ghayas C.
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[9] Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia
Zerbit, Jeremie
Tamburini, Jerome
Goldwirt, Lauriane
Decroocq, Justine
Cayuela, Jean Michel
Chapuis, Nicolas
Contejean, Adrien
Batista, Rui
Bouscary, Didier
Willems, Lise
LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3558 - 3560
[10] Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Haddad, Fadi G.
Kantarjian, Hagop
Short, Nicholas J.
Konopleva, Marina
Jain, Nitin
Huang, Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S204 - S204

← 1 2 3 4 5 →